Skip to main content
. 2023 Jul 19;14:1205031. doi: 10.3389/fneur.2023.1205031

Table 1.

Baseline and clinical characteristics of patients with and without fever within 24 h after hematoma evacuation.

Non-fever group (n = 89) Fever group (n = 219) p value
Age, y, median (IQR) (y) 55 (50–64) 51 (43–60) 0.005
Female sex, n (%) 35 (39.3) 56 (25.6) 0.016
GCS at admission, median (IQR) 8 (6–11) 7 (6–10) 0.083
Systolic blood pressure at admission, median (IQR), (mm Hg) 175 (158–189) 177 (154–198) 0.419
Diastolic blood pressure at admission, median (IQR), (mm Hg) 95 (86–109) 100 (85–112) 0.114
Heart rate at admission, median (IQR) 78 (70–90) 84 (75–90) 0.174
Hypertension 70 (78.7) 162 (74.0) 0.388
Laboratory tests, median (IQR)
WBC × 109/L 8.13 (6.19–10.29) 8.80 (6.83–10.82) 0.007
Serum glucose, mmol/L 6.93 (6.30–8.11) 8.00 (6.75–9.90) 0.069
Hematoma profiles
Hematoma location, n (%) 0.247
Basal ganglia 55 (61.8) 139 (63.5)
Lobe 26 (29.2) 62 (28.2)
Epencephalon 4 (4.5) 14 (6.4)
Thalamus 2 (2.2) 4 (1.8)
Brainstem 2 (2.2) 0 (0)
Intraventricular hemorrhage, n (%) 41 (46.1) 116 (53.0) 0.272
Volume of hematoma, median (IQR) 44.38 (26.08–62.91) 47.63 (28.94–70.68) 0.651
Body temperature profiles, median (IQR)
Body temperature at admission, (°C) 36.5 (36.5–36.7) 36.5 (36.5–36.7) 0.516
Maximum temperature within 24 h, (°C) 37.2 (36.9–37.4) 38.5 (38.0–39.0) <0.001
Minimum temperature within 24 h, (°C) 36.2 (36.0–36.4) 36.9 (36.5–37.3) <0.001
Fever burden, (°C × h) 0.00 (0.00–0.00) 7.00 (2.00–16.60) <0.001
Clinical outcomes
END, n (%) 19 (21.3) 63 (28.8) 0.182
3-month mRS score, median (IQR) 2 (2–5) 3 (2–5) 0.551
3-month poor functional outcome (mRS score > 2), n (%) 44 (49.4) 168 (54.5) 0.251

p value < 0.05 was shown in bold. END, early neurological deterioration; GCS, Glasgow coma score; ICH, intracerebral hemorrhage; IQR, interquartile range; mRS, modified Rankin Scale; WBC, white blood cell count.